Healthcare & Medical Devices Global On demand · 24-48h

Global Human Interleukin Residue Detection Kit Market Strategic Research Report

Global Human Interleukin Residue Detection Kit Market Strate…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Human Interleukin Residue Detection Kit Market
$1492025
12.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: ELISA Kit, CLIA Kit, FIA Kit, GICA Kit

By Application: Biopharmaceutical Research Industry, Life Sciences and Basic Research, Regenerative Medicine and Stem Cell Industry, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific Inc., Cell Signaling Technology, MedChemExpress, Abcam, Enzo Biochem, Merck, ApexBio Technology, Beyotime Biotechnology, Vazyme, Yeasen, Cayman Chemical, Dojindo Laboratories, Jiangsu Puxin Biomedical Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$149
Million USD
Forecast CAGR
12.4%
2025-2032
Forecast 2032
$337.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Human Interleukin Residue Detection Kit market size is predicted to grow from US$ 149 million in 2025 to US$ 333 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.

Human Interleukin Residue Detection Kit is a bioanalytical reagent product used to detect the levels of residual human interleukins (such as IL-2, IL-6, and IL-15) during cell preparation. This kit is commonly used in the quality control and safety evaluation of cell therapy products, recombinant protein drugs, vaccines, and biological agents to ensure the effective removal of exogenous cytokines during the manufacturing process and avoid the risk of immune reactions. The detection principle is typically based on sandwich ELISA or chemiluminescent immunoassay, featuring high sensitivity, strong specificity, and good reproducibility. It can quantitatively determine the level of residual interleukins in samples, providing a scientific basis for release testing and process validation of biological products. In 2025, sales volume was 330,000 units, with an average price of US$422, a single-line production capacity of 30,000 units, and a gross profit margin of 80%.

Global key Human Interleukin Residue Detection Kit players cover Thermo Fisher Scientific Inc., Cell Signaling Technology, MedChemExpress, Abcam, Enzo Biochem, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Interleukin Residue Detection Kit market?

What factors are driving Human Interleukin Residue Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Interleukin Residue Detection Kit market opportunities vary by end market size?

How does Human Interleukin Residue Detection Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Human Interleukin Residue Detection Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • ELISA Kit
  • CLIA Kit
  • FIA Kit
  • GICA Kit

Segment by Target Cytokine Type

  • Human IL-2 Residual Detection Kit
  • Human IL-6 Residual Detection Kit
  • Human IL-7 Residual Detection Kit
  • Human IL-15 Residual Detection Kit

Segment by Detection Throughput and Automation Level

  • Single-Sample Assay Kit
  • High-Throughput Assay Kit

Segment by Application

  • Biopharmaceutical Research Industry
  • Life Sciences and Basic Research
  • Regenerative Medicine and Stem Cell Industry
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Human Interleukin Residue Detection Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biopharmaceutical Research Industry, Life Sciences and Basic Research, Regenerative Medicine and Stem Cell Industry evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Human Interleukin Residue Detection Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$149
2025
Forecast
$337.7
2032
CAGR
12.4%
2025–2032
Regions
5
global
Key companies
Thermo Fisher Scientific Inc.Cell Signaling TechnologyMedChemExpressAbcamEnzo BiochemMerckApexBio TechnologyBeyotime Biotechnology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
ELISA KitCLIA KitFIA KitGICA Kit
By Application
Biopharmaceutical Research IndustryLife Sciences and Basic ResearchRegenerative Medicine and Stem Cell IndustryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 ELISA Kit
  • 3.1.3 CLIA Kit
  • 3.1.4 FIA Kit
  • 3.1.5 GICA Kit
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biopharmaceutical Research Industry
  • 4.1.3 Life Sciences and Basic Research
  • 4.1.4 Regenerative Medicine and Stem Cell Industry
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cell Signaling Technology
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 MedChemExpress
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Abcam
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Enzo Biochem
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Merck
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ApexBio Technology
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Beyotime Biotechnology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vazyme
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Yeasen
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Cayman Chemical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Dojindo Laboratories
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Jiangsu Puxin Biomedical Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Human Interleukin Residue Detection Kit market?
The global Human Interleukin Residue Detection Kit market is estimated at US$ 149 million in 2025 (base year) and is projected to reach US$ 333 million by 2032.
What is the forecast CAGR for the Human Interleukin Residue Detection Kit market?
The market is expected to grow at a CAGR of 12.4% from 2026 to 2032, expanding from US$ 149 million in 2025 to US$ 333 million in 2032, roughly 2.2 times its base-year value.
What is Human Interleukin Residue Detection Kit?
Human Interleukin Residue Detection Kit is a bioanalytical reagent product used to detect the levels of residual human interleukins (such as IL-2, IL-6, and IL-15) during cell preparation. This kit is commonly used in the quality control and safety evaluation of cell therapy products, recombinant protein drugs, vaccines, and biological agents to ensure the effective removal of exogenous cytokines during the manufacturing process and avoid the risk of immune reactions.
What are the main segments of the Human Interleukin Residue Detection Kit market by type?
By type, the market is segmented into ELISA Kit, CLIA Kit, FIA Kit and GICA Kit.
Which applications drive demand in the Human Interleukin Residue Detection Kit market?
Key applications covered include Biopharmaceutical Research Industry, Life Sciences and Basic Research, Regenerative Medicine and Stem Cell Industry and Others.
Who are the key players in the Human Interleukin Residue Detection Kit market?
Key players profiled include Thermo Fisher Scientific Inc., Cell Signaling Technology, MedChemExpress, Abcam, Enzo Biochem, Merck, ApexBio Technology and Beyotime Biotechnology, among 13 companies covered in total.
Which regions and countries are covered for Human Interleukin Residue Detection Kit?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Human Interleukin Residue Detection Kit market?
What factors are driving Human Interleukin Residue Detection Kit market growth, globally and by region?
Who should buy the Human Interleukin Residue Detection Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biopharmaceutical Research Industry, Life Sciences and Basic Research and Regenerative Medicine and Stem Cell Industry, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Human Interleukin Residue Detection Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.